Access Bio, Inc. (KOSDAQ: 950130)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,460.00
-110.00 (-1.97%)
Nov 15, 2024, 9:00 AM KST
-38.93%
Market Cap 191.38B
Revenue (ttm) 101.33B
Net Income (ttm) -15.65B
Shares Out 33.81M
EPS (ttm) -454.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 72,855
Open 5,450.00
Previous Close 5,570.00
Day's Range 5,400.00 - 5,540.00
52-Week Range 5,180.00 - 12,140.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About Access Bio

Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources; analyzers, designed to measure different chemicals and other characteristics in biological samples; and molecular diagnostic solu... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2002
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 950130
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.